Simon Radford looks at the challenges to capacity, and the
constraints inherent in the tax-advantaged sector, in light of the
Patient Capital Review and other trends in the sector.
There is a spectre haunting the tax-advantaged market: the
Patient Capital Review. The thinking of the Treasury is much
remarked upon, but little known, with mentions like that of the
Chancellor's in his party conference speech mined for potential
hints. While many of us have had conversations with policymakers in
terms of the consultation, launched a couple of months ago,
speculation has varied as to their true intentions: some managers
raise the possibility of a National Investment Bank for early-stage
investments, much like those funds deployed by managers as part of
the British Business Bank's "Northern Powerhouse
Investment Funds". Others reassure the sector that changes
will be incremental more than radical, while lobby groups
representing both EIS and VCT managers seem ready to